Partner Sites

GFTN targets growth-stage fintechs with $200m fund

GFTN targets growth-stage fintechs with $200m fund

APAC Islamic banking rebound in 2026 set to mask market divides

APAC Islamic banking rebound in 2026 set to mask market divides

Indian banks hit decade-high returns but profit set to soften

Indian banks hit decade-high returns but profit set to soften

Where to invest in 2026 as tariffs, AI, and currencies collide

Where to invest in 2026 as tariffs, AI, and currencies collide

Shrinking margins threaten bank growth despite fat dividend

Shrinking margins threaten bank growth despite fat dividend

Singapore firms fail transparency test for 39% of locals

Singapore firms fail transparency test for 39% of locals

Capital rules force Indian insurers to curb aggressive discounting

Capital rules force Indian insurers to curb aggressive discounting

Zurich Indonesia speeds up claims after Bali floods

Zurich Indonesia speeds up claims after Bali floods

Seven in 10 APAC insurers expect private equity returns to rise

Seven in 10 APAC insurers expect private equity returns to rise

Capital rules force Indian insurers to curb aggressive discounting

Capital rules force Indian insurers to curb aggressive discounting

Zurich Indonesia speeds up claims after Bali floods

Zurich Indonesia speeds up claims after Bali floods

Seven in 10 APAC insurers expect private equity returns to rise

Seven in 10 APAC insurers expect private equity returns to rise

Tokyo named world’s most liveable city for tech workers

Tokyo named world’s most liveable city for tech workers

Global chip sales hit record $75.3b as Japan lags

Global chip sales hit record $75.3b as Japan lags

Dollar slide, tariffs and AI doubts to test investors in 2026

Dollar slide, tariffs and AI doubts to test investors in 2026

Central vacancy falls as financial firms add space

Central vacancy falls as financial firms add space

High rents, labour costs loom over Jollibee’s Australia plans

High rents, labour costs loom over Jollibee’s Australia plans

Human microbiome drugs market to be valued at $2.13b by 2031

Human microbiome drugs market to be valued at $2.13b by 2031

Indonesia sets 2032 target for first nuclear power plant

Indonesia sets 2032 target for first nuclear power plant